{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:33:21Z","timestamp":1787585601279,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["AMR\/RC\/63\/2014-ECD-II"],"award-info":[{"award-number":["AMR\/RC\/63\/2014-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijmmb.2026.101131","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:01:30Z","timestamp":1778108490000},"page":"101131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The synergy between ceftazidime\/avibactam and aztreonam against metallo-beta-lactamase positive isolates from an oncology center in eastern India"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0357-4806","authenticated-orcid":false,"given":"Soumik","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijon","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchandrima","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4139-1039","authenticated-orcid":false,"given":"Sanjay","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2026.101131_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination","volume":"73","author":"Zhanel","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ijmmb.2026.101131_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/ciz1159","article-title":"Aztreonam combination therapy: an answer to Metallo-\u03b2-Lactamase-Producing gram-negative bacteria?","volume":"71","author":"Shields","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101131_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04925-22","article-title":"In vitro activity of two cefepime-based novel combinations, cefepime\/taniborbactam and cefepime\/zidebactam, against carbapenemase-expressing Enterobacterales collected in India","volume":"11","author":"Bakthavatchalam","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2026.101131_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cmi.2023.12.026","article-title":"Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID\/ISARPAE group","volume":"30","author":"Oliver","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijmmb.2026.101131_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2023.100472","article-title":"Are we looking towards an early demise of ceftazidime\/avibactam (CAZ\/AVI) as an antibiotic?","volume":"46","author":"Bhattacharya","year":"2023","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101131_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/INF.0000000000001859","article-title":"Ceftazidime-avibactam antimicrobial activity and spectrum when tested against gram-negative organisms from pediatric patients: results from the INFORM surveillance program (United States, 2011-2015)","volume":"37","author":"Sader","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijmmb.2026.101131_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/phar.4629","article-title":"Aztreonam-avibactam: the dynamic duo against multidrug-resistant gram-negative pathogens","volume":"44","author":"Al Musawa","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijmmb.2026.101131_bib9","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by Metallo-\u03b2-lactamase-Producing Enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101131_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10096-023-04645-2","article-title":"In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa\/Middle East, Asia, and Eurasia for the ATLAS global surveillance program in 2019-2021","volume":"42","author":"Wise","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101131_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-023-00573-3","article-title":"Ceftazidime-avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope","volume":"22","author":"Taha","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijmmb.2026.101131_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijmm.IJMM_19_189","article-title":"Will ceftazidime\/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: lessons learnt from in vitro study","volume":"37","author":"Pragasam","year":"2019","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101131_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/ice.2019.79","article-title":"Rapid and economical detection of eight carbapenem-resistance genes in enterobacteriaceae, pseudomonas spp, and acinetobacter spp directly from positive blood cultures using an internally controlled multiplex-PCR assay","volume":"40","author":"Das","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijmmb.2026.101131_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41429-022-00537-3","article-title":"In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallo-beta-lactamase producing organisms: role of combination drugs in antibiotic resistance era","volume":"75","author":"Sreenivasan","year":"2022","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijmmb.2026.101131_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00785-21","article-title":"Evaluation of rapid immunochromatographic tests for the direct detection of extended spectrum beta-lactamases and carbapenemases in Enterobacterales isolated from positive blood cultures","volume":"9","author":"Keshta","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2026.101131_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107256","article-title":"Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability","volume":"64","author":"Tellapragada","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijmmb.2026.101131_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107425","article-title":"Multiple mechanisms mediate aztreonam-avibactam resistance in klebsiella pneumoniae: driven by KPC-2 and OmpK36 mutations","volume":"65","author":"Xiang","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijmmb.2026.101131_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00953-24","article-title":"Assessment of broth disk elution method for aztreonam in combination with ceftazidime\/avibactam against Enterobacterales isolates","volume":"12","author":"Song","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijmmb.2026.101131_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jgar.2022.01.025","article-title":"A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)-producing Enterobacterales infection","volume":"29","author":"Rawson","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijmmb.2026.101131_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/23744235.2020.1788224","article-title":"Phenotypic synergy testing of ceftazidime-avibactam with aztreonam in a university hospital having high number of metallo-beta-lactamase producing bacteria","volume":"52","author":"Sahu","year":"2020","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.ijmmb.2026.101131_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2024.100705","article-title":"Synergy testing of ceftazidime-avibactam and aztreonam combination by two different methods","author":"Rajni","year":"2024","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101131_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00846-21","article-title":"Evaluation of susceptibility testing methods for aztreonam and ceftazidime-avibactam combination therapy on extensively drug-resistant gram-negative organisms","volume":"65","author":"Khan","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:28:46Z","timestamp":1787128126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085726000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"alternative-id":["S0255085726000897"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101131","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synergy between ceftazidime\/avibactam and aztreonam against metallo-beta-lactamase positive isolates from an oncology center in eastern India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101131"}}